Scientists have created a drug which they say could protect people from the effects of a nuclear attack. The drug, currently called HE2100, has been developed by US company Hollis-Eden Pharmaceuticals. Company bosses say it would protect most people outside the immediate ring of a nuclear attack. Early tests suggest it can stem the loss of infection-fighting cells in the body and stop bleeding. High levels of radiation destroy white blood cells which are essential for protecting the body against infection. Death can also be caused by bleeding, as radiation also destroys the ability of blood clots to form. Scientists at Hollis-Eden have tested the drug on animals. The drug cannot be tested in humans because it would be too dangerous to expose them to radiation. Full Story
About OODA Analyst
OODA is comprised of a unique team of international experts capable of providing advanced intelligence and analysis, strategy and planning support, risk and threat management, training, decision support, crisis response, and security services to global corporations and governments.